WallStSmart

CareCloud Inc. (CCLD)vsHealthEquity Inc (HQY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 990% more annual revenue ($1.31B vs $120.50M). HQY leads profitability with a 16.4% profit margin vs 9.0%. HQY trades at a lower P/E of 33.4x. HQY earns a higher WallStSmart Score of 68/100 (B-).

CCLD

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 7.0Value: 8.3Quality: 7.0
Piotroski: 5/9Altman Z: 2.36

HQY

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 10.0Quality: 6.5
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCLDUndervalued (+52.1%)

Margin of Safety

+52.1%

Fair Value

$4.68

Current Price

$3.50

$1.18 discount

UndervaluedFair: $4.68Overvalued
HQYUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$115.13

Current Price

$82.47

$32.66 discount

UndervaluedFair: $115.13Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCLD4 strengths · Avg: 8.8/10
EPS GrowthGrowth
57.4%10/10

Earnings expanding 57.4% YoY

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

HQY3 strengths · Avg: 8.7/10
EPS GrowthGrowth
92.4%10/10

Earnings expanding 92.4% YoY

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

CCLD2 concerns · Avg: 3.5/10
P/E RatioValuation
34.3x4/10

Premium valuation, high expectations priced in

Market CapQuality
$145.75M3/10

Smaller company, higher risk/reward

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : CCLD

The strongest argument for CCLD centers on EPS Growth, Debt/Equity, Price/Book. Revenue growth of 21.9% demonstrates continued momentum.

Bull Case : HQY

The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bear Case : CCLD

The primary concerns for CCLD are P/E Ratio, Market Cap.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Key Dynamics to Monitor

CCLD profiles as a growth stock while HQY is a mature play — different risk/reward profiles.

CCLD carries more volatility with a beta of 2.15 — expect wider price swings.

CCLD is growing revenue faster at 21.9% — sustainability is the question.

HQY generates stronger free cash flow (102M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (68/100 vs 54/100), backed by strong 16.4% margins. CCLD offers better value entry with a 52.1% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareCloud Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. The company is headquartered in Somerset, New Jersey.

Visit Website →

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Want to dig deeper into these stocks?